Keywords: ergo, dopamine, agonist, shows, promise, type, ii

Ergo Dopamine Agonist Shows Promise In Type II Diabetes

Article | 12 June 1997

Print This

Phase III results have revealed that Ergo Sciences' lead drug candidatefor diabetes, Ergoset, can effectively reduce blood glucose levels and ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in